Illumina Names New Executives, Denator Brings Aboard Sales Execs, King and Cassigneul Join PMC Board, and More | GenomeWeb
This article has been updated from a previous version to correct Stephen Pentoney's title. He has been appointed vice president of assay and reagent development at Illumina, not as VP of array biochemistry as the company had previously reported.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.